GSK

  • Avodart 2014 report

    Avodart 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 22 Pages The 5 Key Questions Addressed by this...

  • Benlysta 2014 report

    Benlysta 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 22 Pages The 5 Key Questions Addressed by this Report:...

  • Boostrix 2014 report

    Boostrix 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 25 Pages The 5 Key Questions Addressed by this...

  • Breo Ellipta 2014 report

    Breo Ellipta 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 22 Pages The 5 Key Questions Addressed by...

  • Engerix 2014 report

    Engerix 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 25 Pages The 5 Key Questions Addressed by this...

  • Flovent 2014 report

    Flovent 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 27 Pages The 5 Key Questions Addressed by this...

  • Fluarix 2014 report

    Fluarix 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 25 Pages The 5 Key Questions Addressed by this...

  • Havrix 2014 report

    Havrix 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 25 Pages The 5 Key Questions Addressed by this...

  • Infanrix 2014 report

    Infanrix 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 22 Pages The 5 Key Questions Addressed by this...

  • Jalyn 2014 report

    Jalyn 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 22 Pages The 5 Key Questions Addressed by this...

  • Kinrix 2014 report

    Kinrix 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 23 Pages The 5 Key Questions Addressed by this...

  • Levitra 2014 report

    Levitra 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 25 Pages The 5 Key Questions Addressed by this...